• 1. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 2. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 3. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
• 4. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 5. An alternative biorefinery approach to address microalgal seasonality: blending with spent coffee grounds
  Andre Prates Pereira,Tao Dong,Eric P. Knoshaug,Nick Nagle,Ryan Spiller,Bonnie Panczak,Christopher J. Chuck,Philip T. Pienkos Sustainable Energy Fuels, 2020,4, 3400-3408

4-Methoxy-1H-indazole-3-carboxylic Acid: A Comprehensive Overview

The compound 4-Methoxy-1H-indazole-3-carboxylic acid (CAS No. 865887-02-1) is a structurally unique organic compound belonging to the indazole family. Indazoles are heterocyclic aromatic compounds consisting of a benzene ring fused to an imidazole ring, and they have gained significant attention in the fields of medicinal chemistry and pharmacology due to their diverse biological activities. The presence of the methoxy group at the 4-position and the carboxylic acid group at the 3-position in this compound introduces additional functional groups that can influence its chemical properties, bioavailability, and therapeutic potential.

Recent studies have highlighted the importance of indazole derivatives in drug discovery, particularly in the development of anti-inflammatory, anticancer, and antimicrobial agents. The 4-methoxy substitution in this compound is known to enhance its lipophilicity, which can improve its ability to cross biological membranes and reach target sites within the body. This property makes it a promising candidate for drug delivery systems and targeted therapies. Additionally, the carboxylic acid group at the 3-position can participate in hydrogen bonding, which is crucial for interactions with biological macromolecules such as proteins and nucleic acids.

One of the most exciting developments involving 4-Methoxy-1H-indazole-3-carboxylic acid is its potential role in anticancer therapy. Researchers have demonstrated that this compound exhibits selective cytotoxicity against various cancer cell lines, including breast, colon, and lung cancer cells. The mechanism of action appears to involve induction of apoptosis through modulation of key signaling pathways such as the PI3K/AKT/mTOR pathway. These findings suggest that this compound could serve as a lead molecule for the development of novel anticancer agents with improved efficacy and reduced side effects compared to conventional chemotherapeutic drugs.

In addition to its anticancer properties, 4-Methoxy-1H-indazole-3-carboxylic acid has shown promise in anti-inflammatory applications. Experimental data indicate that this compound inhibits the production of pro-inflammatory cytokines such as TNF-alpha and IL-6 in activated macrophages. This anti-inflammatory activity is attributed to its ability to suppress NF-kB signaling, a key regulator of inflammatory responses. Given the growing need for safer and more effective anti-inflammatory agents, this compound represents a valuable addition to the pipeline of potential therapeutic candidates.

The synthesis of 4-Methoxy-1H-indazole-3-carboxylic acid involves a multi-step process that typically begins with the preparation of indazole derivatives followed by functionalization at specific positions. Recent advancements in synthetic chemistry have enabled researchers to optimize reaction conditions, leading to higher yields and improved purity of the final product. For instance, microwave-assisted synthesis has been employed to accelerate certain steps while maintaining control over stereochemistry and regioselectivity.

From an analytical standpoint, 4-Methoxy-1H-indazole-3-carboxylic acid has been characterized using a variety of spectroscopic techniques including UV-vis spectroscopy, NMR spectroscopy, and mass spectrometry. These analyses have provided detailed insights into its molecular structure, stability under different conditions, and potential for degradation products formation. Such information is critical for ensuring the quality and consistency of pharmaceutical formulations containing this compound.

Looking ahead, ongoing research is focused on exploring the pharmacokinetic properties of 4-Methoxy-1H-indazole-3-carboxylic acid, including its absorption, distribution, metabolism, and excretion profiles in preclinical models. Understanding these parameters will be essential for determining its suitability as an oral or parenteral therapeutic agent. Furthermore, efforts are underway to identify additional biological targets that may be modulated by this compound, potentially expanding its therapeutic applications beyond cancer and inflammation.

In conclusion, 4-Methoxy-1H-indazole-3-carboxylic acid (CAS No. 865887-02-1) represents a compelling candidate for drug development due to its unique chemical structure and diverse biological activities. With ongoing research uncovering new insights into its mechanisms of action and therapeutic potential, this compound holds great promise for addressing unmet medical needs in oncology, inflammation, and other disease areas.

• 90417-53-1(5-Methoxy-1H-indazole-3-carboxylic Acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)